Research on colon cancer suggested that the downregulation of NOS, COX-2, HIF-1α, VEGF, Ang-2, and Ang-4 was the result of SB treatment (Singh et al., 2008; Sameri et al., 2021). This evidence concerns the gene PTGS2 and malignant colon neoplasm.